Estrogenic compounds as anti-angiogenic agents
US5504074A · kind A · utility
112Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 1993 |
| Grant date | Apr 2, 1996 |
| Priority date | — |
| Expiry date | Aug 6, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J63/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application discloses methods of treating mammalian diseases characterized by undesirable angiogenesis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.